ARTHRITIS DRUG ADDS WARNING

Beth Janicek

Attorney
(866) 735-1102 Ext 395

0 CommentsPrint ArticleSubscribe

Amgen and Wyeth adds strongest U.S. Food and Drug Administration warning to the prescribing information for the arthritis drug Enbrel. Amgen who manufactures the drug has now highlighted the risk of infections, including tuberculosis. The warning, already in boldface, must now be highlighted inside a boxed border, the so- called "black box" warning. In studies of more than 20,000 patients taking Enbrel, 200 of them had tuberculosis.
Last week, the U.S. Food and Drug Administration advisory panel, recommended restrictions be added on the use of Amgen anemia drugs, including its top-seller Aranesp for cancer patients.